Sign Up to like & get
recommendations!
1
Published in 2019 at "International Journal of Cancer"
DOI: 10.1002/ijc.32326
Abstract: Five‐year overall survival of stage III colorectal cancer (CRC) patients treated with standard adjuvant chemotherapy (ACHT) is highly variable. Genomic biomarkers and/or transcriptomic profiles identified lack of adequate validation. Aim of our study was to…
read more here.
Keywords:
stage iii;
pnn kcnq1ot1;
crc patients;
cancer ... See more keywords